Literature DB >> 16430723

Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.

Y Marcus-Perlman1, K Tordjman, Y Greenman, R Limor, G Shenkerman, E Osher, N Stern.   

Abstract

OBJECTIVES: Salivary cortisol is unaffected by cortisol binding globulin (CBG) and hence allows CBG-related variations in serum total cortisol to be bypassed. We assessed whether or not salivary cortisol can be used for the low-dose (1 microg) ACTH test in subjects with presumed normal and elevated levels of CBG. PATIENTS/
METHODS: We measured serum and salivary cortisol responses to intravenous administration of 1 microg ACTH in 14 healthy volunteers, 14 'hyperoestrogenic' women [in their first or early second trimester of pregnancy, using oral contraceptives (OC) or on hormone replacement therapy (HRT)] and 10 patients with secondary hypoadrenalism. Cortisol levels were recorded before as well as 30 and 60 min (+30; +60 min) after ACTH administration.
RESULTS: Baseline salivary cortisol did not differ significantly between the hypoadrenal and healthy patients (7.11+/-1.4 and 12.13+/-1.59 nmol/l; P=0.48) but there was a significant difference between hypoadrenal and hyperoestrogenic patients (18.94+/- 3.44 nmol/l; P=0.01). The largest difference between hypoadrenal patients and healthy individuals was observed at+30 min (9.16+/-2.8, 52.65+/-8.78 and 48.81+/- 6.9 nmol/l, in the hypoadrenal, healthy and hyperoestrogenic patients, respectively; P< 0.05). At this time-point values< 24.28 nmol/l were found in all hypoadrenal patients and cortisol levels >or= 27.6 nmol/l were found in 26 out of 28 healthy volunteers. ACTH-stimulated serum cortisol but not salivary cortisol was significantly higher in hyperoestrogenic women than in the healthy volunteers at either+30 or+60 min.
CONCLUSIONS: The salivary low-dose ACTH test yields results that parallel the response of circulating cortisol to ACTH and may provide an alternative to the blood test, particularly in situations where increased CBG levels complicate the changes in serum cortisol levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430723     DOI: 10.1111/j.1365-2265.2006.02451.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  Performance of low-dose cosyntropin stimulation test handled via plastic tube.

Authors:  Leonard Saiegh; Asala Abu-Ahmad; Mohammad Sheikh-Ahmad; Maria Reut; Limor Chen-Konak; Nizar Jiries; Carmela Shechner
Journal:  Endocrine       Date:  2017-05-22       Impact factor: 3.633

Review 2.  Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management.

Authors:  Kevin C J Yuen; Lindsay E Chong; Christian A Koch
Journal:  Endocrine       Date:  2013-02-02       Impact factor: 3.633

Review 3.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

4.  Characterization of the serum and salivary cortisol response to the intravenous 250 µg ACTH1-24 stimulation test.

Authors:  Brendan J Nolan; Jane Sorbello; Nigel Brown; Goce Dimeski; Warrick J Inder
Journal:  Endocrine       Date:  2018-01-03       Impact factor: 3.633

5.  Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers.

Authors:  Gulsah Elbuken; Fatih Tanriverdi; Zuleyha Karaca; Mustafa Kula; Selma Gokahmetoglu; Kursad Unluhizarci; Fahrettin Kelestimur
Journal:  Endocrine       Date:  2014-08-13       Impact factor: 3.633

6.  Salivary cortisol as an alternative for serum cortisol in the low-dose adrenocorticotropic hormone stimulation test?

Authors:  R K Schindhelm; J J C M van de Leur; J M M Rondeel
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

Review 7.  Secondary hypoadrenalism.

Authors:  Giuseppe Reimondo; Silvia Bovio; Barbara Allasino; Massimo Terzolo; Alberto Angeli
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

8.  Cosyntropin-stimulated salivary cortisol in hospitalized patients with hypoproteinemia.

Authors:  Hershel Raff; Scott Brock; James W Findling
Journal:  Endocrine       Date:  2008-10-23       Impact factor: 3.633

9.  Salivary cortisol in the diagnosis of adrenal insufficiency: cost efficient and patient friendly.

Authors:  Marloes L P Langelaan; Jérôme M H Kisters; Mirjam M Oosterwerff; Arjen-Kars Boer
Journal:  Endocr Connect       Date:  2018-03-12       Impact factor: 3.335

10.  Salivary Cortisol and Cortisone After Low-Dose Corticotropin Stimulation in the Diagnosis of Adrenal Insufficiency.

Authors:  Ingrid Yin Fung Mak; Benjamin Yick Toa Au Yeung; Ying Wai Ng; Cheung Hei Choi; Heidi Yan Ping Iu; Chi Chung Shek; Sau Cheung Tiu
Journal:  J Endocr Soc       Date:  2017-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.